This is a Reach announcement and the
information contained is not considered to be material or to have a
significant impact on management's expectations of the Company's
performance. Reach is an investor communication service aimed at
assisting listed and unlisted (including AIM quoted) companies to
distribute non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for
Companies, Market Abuse Regulation or other regulation would be
disseminated as an RNS regulatory announcement and not on
Reach.
26 February 2024
MicroSalt
plc
("MicroSalt" or the
"Company")
Notice of investor
webinar
MicroSalt plc, (AIM: SALT) a company
commercialising a patented technology to produce full-flavour,
low-sodium salt for food manufacturers and consumers, is pleased to
announce that Rick Guiney (CEO) and Konrad
Dabrowski (CFO), will be presenting at the London South
East/focusIR investor webinar on Tuesday 27 February at 7pm (UK
local time).
Following the presentation,
attendees will have the opportunity to ask questions. If you would
like to attend, you can register for free using the link
below:
Register Here to Attend
For more information, please
visit www.microsaltinc.co,
follow on X @microSaltPLC or contact:
|
MicroSalt
plc
|
Via Flagstaff
|
|
Rick Guiney, CEO
|
|
|
|
|
|
Flagstaff
PR (Financial IR/FPR)
|
+44 (0)20 7129 1474
|
|
Tim Thompson / Alison Allfrey / Anna
Probert
microsalt@flagstaffcomms.com
|
|
Notes to Editors
MicroSalt® produces a patented
full-flavour, low-sodium salt for food manufacturers and
consumers.
MicroSalt is a major potential
disruptor in the food market, thanks to its micron sized particles
which deliver the same sense of saltiness to a wide range of foods
but with approximately 50% less sodium. Excess sodium consumption
is a significant contributor to cardiovascular disease and
MicroSalt's solution meets the rising demand for healthier
alternatives to traditional salt. The WHO has set a
target for reducing global sodium intake by 30% by 2025, which it
estimates will save 7 million lives by 2030.
Each year, cardiovascular disease
costs the UK £19 billion - if the average salt intake was reduced
by one gram per day, it has been estimated that 4,147 lives and
£288 million would be saved each year in the UK. As a nation, the
UK consumes 183 million kilograms of salt each year, and 70% of the
typical person's sodium intake is hidden in processed
foods.
Operational since 2018, MicroSalt
uses a patent-protected technology which helps create high barriers
to entry within the reduced-sodium salt market.
The Directors believe that MicroSalt
is well positioned to capture growth in the low sodium market,
which is expected to grow exponentially, and that there is also
scope to enter the larger salt market.
ENDS